Fructooligosaccharides in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
Conditions
- Hematopoietic and Lymphoid Cell Neoplasm
- Recurrent Hematologic Malignancy
Interventions
- OTHER: Fructooligosaccharide
- OTHER: Laboratory Biomarker Analysis
Sponsor
Stanford University
Collaborators